Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.9%

4 terminated out of 45 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

18%

8 trials in Phase 3/4

Results Transparency

20%

4 of 20 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (18)
Early P 1 (1)
P 1 (3)
P 2 (5)
P 3 (1)
P 4 (7)

Trial Status

Completed20
Unknown15
Terminated4
Recruiting4
Withdrawn1
Active Not Recruiting1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT06246396Phase 4RecruitingPrimary

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

NCT06518915Not ApplicableRecruitingPrimary

Baroloop Multicenter Trial (Baroloop MCT)

NCT02057783Not ApplicableRecruitingPrimary

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension

NCT06664255Completed

High Prevalence of Secondary Arterial Hypertension (HIPRESH) with Prospective Systematic Screening in a Cohort of Consecutive Hypertensive Patients Referring to Regional Specialized Center

NCT06646601Not ApplicableRecruiting

A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.

NCT05017935Not ApplicableActive Not Recruiting

RADIANCE Continued Access Protocol

NCT03730519Not ApplicableTerminated

UK Registry for Baroreflex Activation Therapy

NCT04542681Phase 1WithdrawnPrimary

MANP in African Americans With Hypertension

NCT03757377Not ApplicableUnknownPrimary

Moderato System in Patients With Hypertension

NCT02837445Not ApplicableUnknownPrimary

Moderato System: A Double-Blind Randomized Trial Ver 1.1

NCT05395403Not ApplicableCompleted

Use of Automated Office Blood Pressure Monitoring

NCT02667912Not ApplicableCompletedPrimary

Distal Renal Denervation

NCT02832973Phase 4CompletedPrimary

Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension

NCT01520506Not ApplicableCompletedPrimary

Rapid Renal Sympathetic Denervation for Resistant Hypertension

NCT02559882TerminatedPrimary

How to Test Success of a Renal Denervation

NCT01570777Phase 4CompletedPrimary

Renal Denervation in Hypertension

NCT02653222Phase 2TerminatedPrimary

Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension

NCT02282033Not ApplicableCompletedPrimary

Safety and Performance Study of the Moderato System

NCT02539810Phase 4Terminated

Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

NCT02587533Not ApplicableCompletedPrimary

Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation

Scroll to load more

Research Network

Activity Timeline